Skip to content
Disclosery

Blackcrane Capital, LLC

Follow

13F filer, CIK 1720745, BELLEVUE, WA

Blackcrane Capital, LLC reported $16,325,000 across 7 holdings for the quarter ended 2022-03-31, in a 13F-HR filed 2022-05-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001720745-22-000003

Period
2022-03-31
Reported value
$16.3M
Holdings
7
Top 10 weight
100%
New
0
Sold out
6

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
FERGUSON PLCreduced-72,103-$9.84M
NICEreduced-31,783-$6.96M
PROFreduced-746,351-$6.72M
WIXreduced-38,835-$4.06M
RCELreduced-411,547-$3.49M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2022

Share positions as resolved from 13F-HR 0001720745-22-000003, largest first. % of portfolio is the value over $16,325,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
HDBHDFC BANK LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: 20,978 shares; 2021Q2: 33,965 shares; 2021Q3: 70,630 shares; 2021Q4: 70,630 shares; 2022Q1: 57,807 shares 57,807$3.54M21.72%-12,823Timeline
TAKTAKEDA PHARMACEUTICAL CO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q2: 25,723 shares; 2020Q3: 25,723 shares; 2020Q4: 35,236 shares; 2021Q1: 14,571 shares; 2021Q2: 21,469 shares; 2021Q3: 28,278 shares; 2021Q4: 31,138 shares; 2022Q1: 30,201 shares 30,201$3.15M19.29%-937Timeline
FERGUSON PLCFERGUSON PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: not reported; 2021Q1: not reported; 2021Q2: 97,836 shares; 2021Q3: 97,836 shares; 2021Q4: 90,780 shares; 2022Q1: 18,677 shares 18,677$2.55M15.61%-72,103
PROFPROFOUND MED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q2: 175,301 shares; 2020Q3: 196,924 shares; 2020Q4: 341,767 shares; 2021Q1: 445,525 shares; 2021Q2: 543,601 shares; 2021Q3: 783,655 shares; 2021Q4: 1,001,643 shares; 2022Q1: 255,292 shares 255,292$2.3M14.07%-746,351Timeline
WIXWIX COM LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q2: 62,379 shares; 2020Q3: 41,610 shares; 2020Q4: 42,363 shares; 2021Q1: 43,963 shares; 2021Q2: 48,517 shares; 2021Q3: 57,199 shares; 2021Q4: 60,478 shares; 2022Q1: 21,643 shares 21,643$2.26M13.85%-38,835Timeline
NICENICE LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q2: 43,657 shares; 2020Q3: 25,952 shares; 2020Q4: 26,721 shares; 2021Q1: 27,418 shares; 2021Q2: 41,381 shares; 2021Q3: 41,650 shares; 2021Q4: 41,638 shares; 2022Q1: 9,855 shares 9,855$2.16M13.22%-31,783Timeline
RCELAVITA MEDICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q2: 921,663 shares; 2020Q3: 474,982 shares; 2020Q4: 308,504 shares; 2021Q1: 418,194 shares; 2021Q2: 418,194 shares; 2021Q3: 434,171 shares; 2021Q4: 454,871 shares; 2022Q1: 43,324 shares 43,324$367K2.25%-411,547Timeline

Sold out in Q1 2022

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AXONICS INCAXONICS INC46,716$2.62Mshares
MYOVANT SCIENCES LTDMYOVANT SCIENCES LTD139,552$2.17Mshares
MSFTMICROSOFT CORP4,826$1.62Mshares
ARCO PLATFORM LTDARCO PLATFORM LTD41,886$875Kshares
BABAALIBABA GROUP HLDG LTD6,047$718Kshares
VTEXVTEX64,232$689Kshares

How Q1 2022 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001720745-22-000003 base2022-05-12acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001720745-22-000003 Quarter ended 2022-03-312022-05-12acceptance time not in the bulk data set
13F-HR 0001720745-22-000002 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001720745-21-000005 Quarter ended 2021-09-302021-11-12acceptance time not in the bulk data set
13F-HR 0001720745-21-000004 Quarter ended 2021-06-302021-08-12acceptance time not in the bulk data set
13F-HR 0001720745-21-000003 Quarter ended 2021-03-312021-05-13acceptance time not in the bulk data set
13F-HR 0001720745-21-000001 Quarter ended 2020-12-312021-02-10acceptance time not in the bulk data set
13F-HR 0001720745-20-000005 Quarter ended 2020-09-302020-11-12acceptance time not in the bulk data set
13F-HR 0001720745-20-000004 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001720745-20-000003 Quarter ended 2020-03-312020-05-14acceptance time not in the bulk data set
13F-HR 0001720745-20-000001 Quarter ended 2019-12-312020-02-12acceptance time not in the bulk data set
13F-HR 0001720745-19-000006 Quarter ended 2019-09-302019-11-07acceptance time not in the bulk data set
13F-HR 0001720745-19-000005 Quarter ended 2019-06-302019-08-12acceptance time not in the bulk data set
13F-HR 0001720745-19-000004 Quarter ended 2019-03-312019-05-14acceptance time not in the bulk data set
13F-HR 0001720745-19-000001 Quarter ended 2018-12-312019-01-18acceptance time not in the bulk data set
13F-HR 0001720745-18-000002 Quarter ended 2018-09-302018-10-30acceptance time not in the bulk data set